| Coeptis Therapeutics Holdings, Inc. (BHSE) | 2.06% | $15.56M | N/A | N/A | N/A |
| Vor Biopharma, Inc. (VOR) | 1.56% | $106.79M | N/A | N/A | N/A |
| Vaxxinity, Inc. (VAXX) | 1.39% | $7.03M | N/A | N/A | N/A |
| Gain Therapeutics, Inc. (GANX) | 1.30% | $61.01M | N/A | N/A | N/A |
| Precigen, Inc. (PGEN) | 1.29% | $344.12M | -30.89% | -39.24% | 60.16 |
| MiNK Therapeutics, Inc. (INKT) | 1.24% | $28.97M | N/A | N/A | N/A |
| Cue Biopharma, Inc. (CUE) | 1.20% | $95.66M | 58.86% | 73.65% | 1.67 |
| Verastem, Inc. (VSTM) | 1.17% | $255.02M | N/A | N/A | 6.95 |
| ImmunoPrecise Antibodies Ltd. (IPA) | 1.13% | $16.42M | -0.98% | 46.11% | 1.28 |
| Vaxart, Inc. (VXRT) | 1.09% | $179.66M | 134.79% | 77.70% | 9.40 |
| Champions Oncology, Inc. (CSBR) | 1.07% | $130.87M | 16.56% | 44.93% | 1.10 |
| CorMedix, Inc. (CRMD) | 1.05% | $678.98M | N/A | 94.01% | 35.05 |
| Cognition Therapeutics, Inc. (CGTX) | 1.04% | $31.61M | N/A | N/A | N/A |
| BioVie, Inc. (BIVI) | 1.03% | $40.78M | N/A | N/A | N/A |
| Nascent Biotech, Inc. (NBIO) | 1.03% | $10.33M | N/A | N/A | N/A |
| 23andMe Holding Co. (ME) | 1.03% | $104.96M | -11.86% | 35.53% | 0.63 |
| VistaGen Therapeutics, Inc. (VTGN) | 1.01% | $82.70M | -34.10% | 14.21% | -4.09 |
| INmune Bio, Inc. (INMB) | 1.00% | $121.73M | -100.00% | N/A | 1,861.00 |
| Agenus, Inc. (AGEN) | 1.00% | $73.07M | 3.28% | 86.09% | 3.21 |
| ImmuCell Corp. (ICCC) | 0.98% | $46.25M | 11.40% | 26.34% | 1.74 |
| Bionano Genomics, Inc. (BNGO) | 0.97% | $31.68M | -34.83% | -139.07% | 1.15 |
| Leap Therapeutics, Inc. (LPTX) | 0.97% | $117.25M | N/A | N/A | N/A |
| Carisma Therapeutics, Inc. (SESN) | 0.94% | $19.67M | -11.55% | 78.23% | 0.85 |
| BioXcel Therapeutics, Inc. (BTAI) | 0.94% | $18.73M | -37.24% | -482.71% | 39.74 |
| Curis, Inc. (CRIS) | 0.94% | $28.70M | 3.46% | 97.17% | 4.91 |
| Nuvation Bio, Inc. (NUVB) | 0.94% | $938.43M | N/A | -130.67% | 40.94 |
| IO Biotech, Inc. (IOBT) | 0.93% | $57.38M | N/A | N/A | N/A |
| AlloVir, Inc. (ALVR) | 0.93% | $49.88M | N/A | N/A | N/A |
| ProKidney Corp. (DNAC) | 0.92% | $472.57M | N/A | N/A | N/A |
| Cyclo Therapeutics, Inc. (CYTH) | 0.91% | $17.83M | -52.82% | -268.79% | 38.98 |
| Galectin Therapeutics, Inc. (GALT) | 0.90% | $68.54M | N/A | N/A | N/A |
| Vigil Neuroscience, Inc. (VIGL) | 0.90% | $73.17M | N/A | N/A | N/A |
| Greenwich LifeSciences, Inc. (GLSI) | 0.90% | $162.73M | N/A | N/A | N/A |
| Shattuck Labs, Inc. (STTK) | 0.89% | $56.81M | 336.88% | 68.20% | 14.14 |
| Akoya Biosciences, Inc. (AKYA) | 0.89% | $150.18M | -25.39% | 62.32% | 2.12 |
| Instil Bio, Inc. (TIL) | 0.89% | $129.54M | N/A | N/A | N/A |
| Kodiak Sciences, Inc. (KOD) | 0.89% | $437.83M | N/A | N/A | N/A |
| Co-Diagnostics, Inc. (CODX) | 0.88% | $26.50M | -91.58% | -213.54% | 0.68 |
| Aadi Bioscience, Inc. (AADI) | 0.88% | $88.85M | 21.03% | 88.85% | -0.24 |
| Quince Therapeutics, Inc. (CRTX) | 0.88% | $78.76M | N/A | N/A | N/A |
| iTeos Therapeutics, Inc. (ITOS) | 0.88% | $283.50M | N/A | N/A | -1.22 |
| Syros Pharmaceuticals, Inc. (SYRS) | 0.87% | $6.04M | -100.00% | N/A | 224.15 |
| Aldeyra Therapeutics, Inc. (ALDX) | 0.87% | $294.18M | N/A | N/A | N/A |
| Spero Therapeutics, Inc. (SPRO) | 0.87% | $53.43M | -66.56% | N/A | 0.01 |
| Seer, Inc. (California) (SEER) | 0.87% | $141.52M | -3.12% | 48.07% | -7.01 |
| Taysha Gene Therapies, Inc. (TSHA) | 0.87% | $360.70M | -62.33% | 83.22% | 44.65 |
| Compass Pathways Plc (CMPS) | 0.87% | $241.53M | N/A | N/A | N/A |
| X4 Pharmaceuticals, Inc. (XFOR) | 0.87% | $97.23M | N/A | 45.18% | 69.16 |
| InflaRx NV (IFRX) | 0.87% | $131.31M | 105.64% | 68.59% | 143.61 |
| Invivyd, Inc. (ADGI) | 0.87% | $54.07M | N/A | 85.32% | 1.44 |
| Compugen Ltd. (CGEN) | 0.87% | $146.84M | N/A | 78.98% | 0.88 |
| Nautilus Biotechnology, Inc. (NAUT) | 0.86% | $220.99M | N/A | N/A | N/A |
| MeiraGTx Holdings Plc (MGTX) | 0.86% | $484.55M | 113.80% | -39.73% | 18.85 |
| Ikena Oncology, Inc. (IKNA) | 0.86% | $62.80M | -100.00% | N/A | -70.03 |
| Kezar Life Sciences, Inc. (KZR) | 0.86% | $47.50M | -100.00% | N/A | N/A |
| Athira Pharma, Inc. (ATHA) | 0.85% | $21.85M | N/A | N/A | N/A |
| Adaptimmune Therapeutics Plc (ADAP) | 0.85% | $158.65M | 467.86% | 93.11% | 0.75 |
| OncoCyte Corp. (OCX) | 0.85% | $37.21M | -73.19% | -233.04% | 56.01 |
| Heron Therapeutics, Inc. (HRTX) | 0.84% | $235.75M | 4.38% | 71.17% | 2.99 |
| Humacyte, Inc. (HUMA) | 0.84% | $593.16M | N/A | N/A | N/A |
| Nkarta, Inc. (NKTX) | 0.84% | $165.84M | N/A | N/A | N/A |
| Spyre Therapeutics, Inc. (AGLE) | 0.84% | $1.32B | N/A | N/A | N/A |
| Avid Bioservices, Inc. (CDMO) | 0.84% | $793.78M | 31.84% | -6.11% | 5.37 |
| Poseida Therapeutics, Inc. (PSTX) | 0.84% | $925.92M | 667.19% | 98.19% | 0.86 |
| Ventyx Biosciences, Inc. (VTYX) | 0.84% | $147.08M | N/A | N/A | N/A |
| eFFECTOR Therapeutics, Inc. (EFTR) | 0.83% | $0.00M | N/A | N/A | N/A |
| Affimed NV (AFMD) | 0.83% | $17.97M | -92.02% | N/A | 43.85 |
| Passage Bio, Inc. (PASG) | 0.83% | $41.38M | N/A | N/A | N/A |
| Voyager Therapeutics, Inc. (VYGR) | 0.83% | $297.71M | 433.79% | 95.40% | 0.23 |
| Trevi Therapeutics, Inc. (TRVI) | 0.83% | $341.38M | N/A | N/A | N/A |
| Fate Therapeutics, Inc. (FATE) | 0.83% | $166.86M | 58.13% | -49.87% | 15.93 |
| LAVA Therapeutics NV (LVTX) | 0.82% | $25.66M | -100.00% | N/A | -3.82 |
| Century Therapeutics, Inc. (IPSC) | 0.81% | $84.18M | 434.46% | -316.81% | 0.49 |
| C4 Therapeutics, Inc. (CCCC) | 0.81% | $258.71M | 38.75% | 86.62% | 6.19 |
| Immunome, Inc. (IMNM) | 0.81% | $661.62M | -18.37% | 80.38% | 63.46 |
| Rani Therapeutics Holdings, Inc. (RANI) | 0.81% | $71.78M | N/A | N/A | N/A |
| Solid Biosciences, Inc. (SLDB) | 0.81% | $147.03M | N/A | N/A | N/A |
| Xeris Biopharma Holdings, Inc. (XERS) | 0.80% | $506.88M | 12.31% | 69.96% | 3.34 |
| TScan Therapeutics, Inc. (TCRX) | 0.80% | $147.84M | -73.01% | 2.10% | 43.83 |
| Climb Bio, Inc. (ELYM) | 0.80% | $134.45M | N/A | N/A | N/A |
| Precision BioSciences, Inc. (DTIL) | 0.79% | $44.98M | -95.61% | -75.52% | -0.07 |
| Enlivex Therapeutics Ltd. (ENLV) | 0.79% | $25.18M | N/A | N/A | N/A |
| PepGen Inc. (PEPG) | 0.79% | $96.81M | N/A | N/A | N/A |
| Spruce Biosciences, Inc. (SPRB) | 0.79% | $15.28M | -80.41% | 98.34% | -5.24 |
| Neoleukin Therapeutics, Inc. (NLTX) | 0.79% | $244.73M | N/A | N/A | 632.97 |
| Larimar Therapeutics, Inc. (LRMR) | 0.79% | $233.53M | N/A | N/A | N/A |
| uniQure NV (QURE) | 0.78% | $740.11M | 62.54% | -75.21% | 10.47 |
| CARA Therapeutics, Inc. (CARA) | 0.78% | $21.71M | -47.47% | 97.14% | 2.00 |
| Reneo Pharmaceuticals, Inc. (RPHM) | 0.78% | $24.26M | N/A | N/A | N/A |
| Seres Therapeutics, Inc. (MCRB) | 0.77% | $144.15M | -100.00% | N/A | 2,675.13 |
| Enzo Biochem, Inc. (ENZ) | 0.77% | $35.53M | -20.41% | 36.70% | 0.52 |
| AVROBIO, Inc. (AVRO) | 0.77% | $557.78M | N/A | N/A | N/A |
| Replimune Group, Inc. (REPL) | 0.77% | $833.27M | N/A | N/A | N/A |
| HOOKIPA Pharma, Inc. (HOOK) | 0.77% | $21.27M | -31.51% | 85.12% | -0.06 |
| Omega Therapeutics, Inc. (OMGA) | 0.76% | $39.09M | 214.32% | -18.64% | 20.35 |
| Black Diamond Therapeutics, Inc. (BDTX) | 0.76% | $109.21M | N/A | N/A | N/A |
| Aspira Women's Health, Inc. (AWH) | 0.76% | $11.06M | 1.80% | 60.04% | 1.39 |
| Foghorn Therapeutics, Inc. (FHTX) | 0.75% | $239.05M | -55.33% | 91.03% | 13.89 |
| Altimmune, Inc. (ALT) | 0.75% | $488.63M | -98.62% | -640.00% | 5,746.38 |
| HCW Biologics Inc. (HCWB) | 0.74% | $14.03M | -50.02% | -10.12% | 9.21 |
| Prelude Therapeutics, Inc. (PRLD) | 0.73% | $58.34M | N/A | 86.50% | 7.18 |
| SAB Biotherapeutics, Inc. (SABS) | 0.72% | $35.44M | -100.00% | N/A | -0.58 |
| Monte Rosa Therapeutics, Inc. (GLUE) | 0.72% | $350.19M | N/A | 77.18% | 15.77 |
| Anixa Biosciences, Inc. (ANIX) | 0.70% | $72.40M | -100.00% | N/A | N/A |
| Mersana Therapeutics, Inc. (MRSN) | 0.68% | $88.94M | 63.65% | 96.81% | 3.11 |
| Design Therapeutics, Inc. (DSGN) | 0.68% | $255.93M | N/A | N/A | N/A |
| BioAtla, Inc. (BCAB) | 0.67% | $30.85M | N/A | 97.93% | 2.71 |
| Graphite Bio, Inc. (GRPH) | 0.67% | $637.55M | N/A | N/A | N/A |
| Stoke Therapeutics, Inc. (STOK) | 0.64% | $476.70M | 47.94% | 77.30% | 27.38 |
| Elutia, Inc. (AZYO) | 0.58% | $112.67M | -3.35% | 46.29% | 5.79 |
| XBiotech, Inc. (XBIT) | 0.52% | $118.28M | N/A | N/A | N/A |
| Gritstone bio, Inc. (GRTS) | 0.50% | $0.77M | -85.75% | -2,707.02% | 270.26 |
| Renovaro, Inc. (ENOB) | 0.42% | $125.77M | N/A | N/A | N/A |
| Sangamo Therapeutics, Inc. (SGMO) | 0.41% | $243.07M | 425.77% | 95.70% | 3.33 |
| Jasper Therapeutics, Inc. (JSPR) | 0.27% | $105.76M | N/A | N/A | N/A |